PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Clarification of recent analyst report on Patent Protection, page-60

  1. 7,909 Posts.
    lightbulb Created with Sketch. 627
    In hindsight……..Morgan’s research is really not that good
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.